tirzepatida

The Obesity Treatment Revolution: Beyond Tirzepatide, Towards Personalized Metabolic Control Nearly 42% of American adults are obese, a figure that isn’t just a health crisis, but a looming economic one, projected to cost the US healthcare system $147 billion annually by 2030. While lifestyle interventions remain crucial, the emergence of drugs like Tirzepatide and Semaglutide … Read more